Acid absorbing agent for preparing cinchona alkaloids ligand

A technology for cinchona alkaloids and ligands, which is applied in the field of acid binding agents, can solve the problems of difficulty in accurate quantification, danger, easy combustion, etc., and achieves the effects of avoiding the column chromatography process, easy operation and safe use.

CN1733762AInactive Publication Date: 2006-02-15FOURTH MILITARY MEDICAL UNIVERSITY
0 Cites 1 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Publication Date
2006-02-15
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses the use of CaH2 in synthesizing cinchona alkaloid ligand, wherein the ligand has a structure disclosed in the specification. CaH2 can be used as the acid binder in synthesizing cinchona alkaloid ligand. monosubstituted product or disubstituted product including hydroquinine, Quinidine, Dihydroquinidine and their derivatives.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to an acid-binding agent in the synthesis process of preparing chiral cinchona alkaloid ligands. This type of ligands can be effectively used in asymmetric dihydroxylation and aminohydroxylation reactions of olefins. Background technique

[0002] Chirality is one of the characteristics of nature and the basis of all life. Life phenomena depend on the existence and recognition of chirality. All animals, plants and the human body have precise chiral recognition capabilities for drugs. The configurations of chiral drugs are different, and their physiological activities and toxicity are also different. L-dopa is a good medicine for treating Parkinson's disease, but D-dopa has serious side effects. (S)-naproxen is 35 times more potent than the (R)-isomer. Therefore, how to obtain chiral compounds has become a severe challenge for chemists. Although optically pure compounds can be obtained through classic racemate resolution and chi...

Examples

Embodiment 1

[0030] Example 1: Synthesis of Ligand 1

[0031] Add 0.295g (0.0015mol) 1,4-dichloro-2,3-naphthyridine, 0.975g (0.003mol) dihydroquinine, 0.63g (0.015mol) CaH 2 , 4.5mL DMF, N 2 Protected, reacted at 90°C, the reaction solution was a light yellow turbid solution, the reaction process was monitored by TLC until the raw materials disappeared, and the reaction time was 1 h in total. Add 10mL ethyl acetate and 5mL water and stir, separate the water layer, extract with ethyl acetate (15mL×3), combine the organic phases, anhydrous MgSO 4 dry. After filtering and concentrating under reduced pressure to leave about 3 mL of liquid, white needle-like crystals precipitated out, dried, and washed with a little anhydrous ether to obtain white crystals, with a yield of 95%. m.p.133~135℃. 1 HNMR (CDCl 3 , internal standard TMS): δ8.65(d, J=4.6Hz, 2H), 8.33(m, 2H), 7.98(d, J=9.2Hz, 2H), 7.96(m, 2H), 7.56(d, 2H), 7.44(d, J=4.7Hz, 2H), 7.36(d, 1H), 7.35(d, 1H), 7.01(d, 2H), 3.9(s, 6H), 3....

Embodiment 2

[0032] Embodiment 2: the synthesis of ligand 2

[0033] In a 100mL three-necked flask, add 0.295g (0.0015mol) 1,4-dichloro-2,3-naphthyridine, 0.975g (0.003mol) dihydroquinidine, 0.63g (0.015mol) CaH 2 , 4.5mL N, N-dimethylformamide (DMF), N 2 Protected, reacted at 90°C, the reaction solution was a light yellow turbid solution, the reaction process was monitored by TLC until the raw materials disappeared, and the reaction time was 5 hours in total. Add 10mL ethyl acetate and 5mL water and stir, separate the water layer, extract with ethyl acetate (15mL×3), combine the organic phases, anhydrous MgSO 4 dry. After filtering and concentrating under reduced pressure to leave about 3 mL of liquid, white needle-like crystals precipitated out, dried, and washed with a little anhydrous ether to obtain white crystals with a yield of 78%. m.p.176-178°C. 1 H NMR (CDCl 3 , internal standard TMS): δ8.65(d, J=5.3Hz, 2H), 8.33(m, 2H), 7.98(d, J=9.2Hz, 2H), 7.94(m, 2H), 7.58(d, 2H), 7.43(...

Embodiment 3

[0034] Embodiment 3: the synthesis of ligand 3

[0035] Add 0.295g (0.0015mol) 1,4-dichloro-2,3-naphthalene, 0.97g (0.003mol) quinine, 0.63g (0.015mol) CaH to a 100mL three-necked flask 2 , 4.5mL DMF, N 2Protected, reacted at 90°C, the reaction solution was a light yellow turbid solution, the reaction process was monitored by TLC until the raw materials disappeared, and the reaction time was 6 hours in total. Add 10mL ethyl acetate and 5mL water and stir, separate the water layer, extract with ethyl acetate (15mL×3), combine the organic phases, anhydrous MgSO 4 dry. After filtering and concentrating under reduced pressure to leave about 3 mL of liquid, white needle-like crystals precipitated out, dried, and washed with a little anhydrous ether to obtain white crystals, with a yield of 95%. m.p.160~161℃. 1 H NMR (CDCl 3 , internal standard TMS): δ8.65 (d, J=5.3Hz, 2H, Ar-H), 8.33 (m, 2H, Ar-H), 7.98 (d, J=9.2Hz, 2H, Ar-H) , 7.96(m, 2H, Ar-H), 7.58(s, 2H, Ar-H), 7.44(d, J=...